radiopharmaceuticals

Abdera skyrockets out of stealth with $142M as radiopharmaceutical ambitions take flight
Fierce Biotech
Thu, 04/20/23 - 11:45 am
Abdera Therapeutics
radiopharmaceuticals
Aiming at mainstream markets, radiopharmaceutical partners engineer $260M cash deal
Endpoints
Mon, 11/14/22 - 10:42 am
Point Biopharma
radiopharmaceuticals
With fresh $160M, RayzeBio plots sprint through the clinic for lead radiopharmaceutical program — building on Novartis' success
Endpoints
Tue, 09/13/22 - 07:54 pm
RayzeBio
radiopharmaceuticals
Merck backs radiopharmaceutical startup Aktis, joining other high-profile backers
BioPharma Dive
Thu, 08/25/22 - 10:55 am
Aktis Oncology
radiopharmaceuticals
Merck
Novartis
Bristol Myers Squibb
Australia-based Telix Pharmaceuticals inks oncology deal with Eli Lilly
Bio Spectrum Asia
Mon, 04/11/22 - 10:36 am
Telix Pharmaceuticals
Eli Lilly
radiopharmaceuticals
olaratumab
soft tissue sarcoma
Curie Therapeutics unveils $75M to widen scope of radiopharmaceuticals for cancer
MedCity News
Wed, 12/1/21 - 10:10 am
Curie Therapeutics
radiopharmaceuticals
funding
cancer
After Big Pharma sparked interest in the US, Ablaze looks to bring radiopharmaceuticals overseas
Endpoints
Tue, 11/30/21 - 10:26 am
Ablaze Pharmaceuticals
funding
RayzeBio
China
radiopharmaceuticals
TRTs
Crinetics Pharma Spinout Launches with Sight Set on Radiopharmaceuticals
BioSpace
Wed, 10/20/21 - 10:09 am
Crinetics Pharmaceuticals
radiopharmaceuticals
spinoffs
Radionetics Oncology
Novartis sets the tone for the radiopharma push with a prized acquisition winning breakthrough therapy designation
Endpoints
Thu, 06/17/21 - 11:09 am
Novartis
radiopharmaceuticals
breakthrough therapy
FDA
Lu-PSMA-617
Just shy of its 1-year anniversary, radiopharmaceuticals platform play RayzeBio bags another megaround
Endpoints
Tue, 06/15/21 - 10:43 am
RayzeBio
funding
radiopharmaceuticals
Are radiopharmaceuticals ready for the mainstream? Novartis, Bristol Myers Squibb bet yes on MPM's platform take
Endpoints
Thu, 03/18/21 - 10:51 am
MPM Capital
radiopharmaceuticals
Novartis
Bristol Myers Squibb
Barely two months after unveiling a new breed of radiopharmaceuticals, RayzeBio brings total haul to $150M
Endpoints
Tue, 12/8/20 - 10:52 am
RayzeBio
radiopharmaceuticals
Versant
venBio
Fusion Pharma teams up with AstraZeneca in next-gen radiopharmaceuticals for cancer
Seeking Alpha
Mon, 11/2/20 - 10:33 am
AstraZeneca
Fusion Pharmaceuticals
radiopharmaceuticals
cancer
Novartis bet $6B on the idea — now Versant, venBio have $45M to birth a platform play for radiopharmaceuticals
Endpoints
Wed, 10/14/20 - 10:51 am
Versant Ventures
PSMA-617
radiopharmaceuticals
prostate cancer
Novartis
Rayze Bio
venBio
Clovis strikes 3B deal to move into radiopharmaceuticals
Fierce Biotech
Mon, 09/23/19 - 10:42 am
Clovis Oncology
radiopharmaceuticals
3B Pharmaceuticals
Another day, another $100M-plus biotech megaround as radiopharmaceuticals’ popularity grows
Endpoints
Tue, 04/2/19 - 12:20 pm
Fusion Pharmaceuticals
radiopharmaceuticals
Novartis
All in: Novartis adds another drug to its fast-growing radiopharmaceuticals division
Endpoints
Mon, 12/3/18 - 12:10 pm
Novartis
oncology
FF-10158
radiopharmaceuticals
Fujifilm Toyama
Advanced Accelerator Application
Novartis to buy French cancer specialist AAA for $3.9 billion
Yahoo/Reuters
Mon, 10/30/17 - 09:58 am
Novartis
M&A
France
Advanced Accelerator Application
radiopharmaceuticals
oncology
Neoprobe partners with Ohio organizations to market cancer drug
Sat, 06/19/10 - 11:23 am
Neoprobe
Lymphoseek
radiopharmaceuticals
breast cancer
melanoma

Pages